Table 1 Baseline characteristics and risk stratification
From: Clinical outcome and hemodynamic behavior of the Labcor Dokimos Plus aortic valve
Characteristic | Number |
|---|---|
Number of patients (n) | 100 |
• Age in years ± standard deviation | 65.9 ± 10.7 |
Gender | |
• Male (n) | 77 |
• Female (n) | 23 |
Body surface area ± standard deviation (m2) | 2.0 ± 0.2 |
Aortic valve lesion | |
• Stenosis (n) | 55 |
• Regurgitation (n) | 25 |
• Mixed lesion (n) | 20 |
• Active endocarditis (n) | 9 |
Predominant cardiac rhythm | |
• Sinus rhythm (n) | 73 |
• Atrial fibrillation (n) | 27 |
Concomitant disease | |
• Coronary artery disease (n) | 38 |
• Arterial hypertension (n) | 67 |
• Pulmonary hypertension (n) | 7 |
• Renal dysfunction (n) | 32 |
• Diabetes mellitus (n) | 22 |
• Obesity (n) | 30 |
NYHA class (Mean ± standard deviation) | 2.6 ± 0.7 |
EuroSCORE II | 3.1 ± 3.9 Range: 0.7-24.5 |
• Isolated aortic valve replacement | 2.0 ± 1.7 Range 0.7-8.2 |
• Complex procedures | 5.9 ± 3.8 Range 0.7-24.5 |